Response to Atreja et al
- PMID: 25646911
- DOI: 10.1038/ajg.2014.377
Response to Atreja et al
Comment on
-
Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.Am J Gastroenterol. 2014 Jun;109(6):811-9. doi: 10.1038/ajg.2014.82. Epub 2014 Apr 29. Am J Gastroenterol. 2014. PMID: 24777151
-
SSRI and the risk of gastrointestinal bleed: more than what meets the eye.Am J Gastroenterol. 2015 Feb;110(2):346. doi: 10.1038/ajg.2014.373. Am J Gastroenterol. 2015. PMID: 25646912 No abstract available.
Similar articles
-
SSRI and the risk of gastrointestinal bleed: more than what meets the eye.Am J Gastroenterol. 2015 Feb;110(2):346. doi: 10.1038/ajg.2014.373. Am J Gastroenterol. 2015. PMID: 25646912 No abstract available.
-
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?Aliment Pharmacol Ther. 2005 Aug 1;22(3):175-81. doi: 10.1111/j.1365-2036.2005.02543.x. Aliment Pharmacol Ther. 2005. PMID: 16091054
-
Association between SSRIs and upper gastrointestinal bleeding. Self treatment with non-steroidal drugs may be confounding factor.BMJ. 2000 May 20;320(7246):1406. BMJ. 2000. PMID: 10858060 No abstract available.
-
[Is the use of selective serotonin reuptake inhibitors associated with an increased risk of bleeding?].Ugeskr Laeger. 2006 Jun 5;168(23):2232-6. Ugeskr Laeger. 2006. PMID: 16768974 Review. Danish.
-
Antidepressants and risk of upper gastrointestinal bleeding.Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):304-10. doi: 10.1111/j.1742-7843.2006.pto_303.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16611206 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical